November 5, 2026StocksTechnology·Bullish·corporate action
Caldera Therapeutics granted exclusive worldwide rights to develop, commercialize Qyuns Therapeutics product candidates
Caldera Therapeutics has been granted exclusive worldwide rights to develop and commercialize product candidates from Qyuns Therapeutics.
Detected & updated continuously · Source: Nebula
Story subjects
Caldera TherapeuticsQyuns Therapeutics